240 related articles for article (PubMed ID: 27299751)
1. [Total thyroidectomy without radioiodine ablation for low-risk thyroid cancer].
Dralle H
Chirurg; 2016 Aug; 87(8):698. PubMed ID: 27299751
[No Abstract] [Full Text] [Related]
2. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma.
Giovanella L; Ceriani L; Ghelfo A; Keller F
Clin Chem Lab Med; 2005; 43(8):843-7. PubMed ID: 16201895
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
4. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
Terris DJ
Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
[No Abstract] [Full Text] [Related]
5. [Postoperative radioiodine ablation in patients with low risk differentiated thyroid carcinoma].
Díez JJ; Grande E; Iglesias P
Med Clin (Barc); 2015 Jan; 144(1):35-41. PubMed ID: 24613061
[TBL] [Abstract][Full Text] [Related]
6. The indications for ablating normal thyroid tissue with 131I in differentiated thyroid cancer.
Goolden AW
Clin Endocrinol (Oxf); 1985 Jul; 23(1):81-6. PubMed ID: 3896581
[No Abstract] [Full Text] [Related]
7. Serum thyroglobulin in patients with early thyroid cancer who have residual thyroid after total thyroidectomy.
Panza N; De Rosa M; Lombardi G; Salvatore M
Lancet; 1984 Feb; 1(8373):398. PubMed ID: 6141460
[No Abstract] [Full Text] [Related]
8. Thyroglobulin-guided (131)I ablation in low-risk differentiated thyroid carcinoma: is the yardstick accurate enough?
Giovanella L
Head Neck; 2011 Sep; 33(9):1379-80; author reply 1380-1. PubMed ID: 21739512
[No Abstract] [Full Text] [Related]
9. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY
Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the factors affecting the efficacy of (131)I remnant ablation in patients after thyroidectomy for papillary thyroid microcarcinoma].
Du F; Hu S; Wu C; Cheng Y; Wu LX; Liu JZ; Wu ZF; Li SJ
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):610-613. PubMed ID: 30139032
[No Abstract] [Full Text] [Related]
11. Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
Vaisman A; Orlov S; Yip J; Hu C; Lim T; Dowar M; Freeman JL; Walfish PG
Head Neck; 2010 Jun; 32(6):689-98. PubMed ID: 20187016
[TBL] [Abstract][Full Text] [Related]
12. [Controversies in the follow-up and management of well-differentiated thyroid cancer. New answers to old questions].
Abós Olivares MD; Pesquera González C
Rev Esp Med Nucl; 2005; 24(3):207-15. PubMed ID: 15847791
[No Abstract] [Full Text] [Related]
13. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer.
Caglar M; Bozkurt FM; Akca CK; Vargol SE; Bayraktar M; Ugur O; Karaağaoğlu E
Nucl Med Commun; 2012 Mar; 33(3):268-74. PubMed ID: 22205241
[TBL] [Abstract][Full Text] [Related]
14. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
Moser E; Fritsch S; Braun S
Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
[TBL] [Abstract][Full Text] [Related]
15. Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?
Rosario PW; Mourão GF; dos Santos JB; Calsolari MR
Thyroid; 2014 Mar; 24(3):533-6. PubMed ID: 24067080
[TBL] [Abstract][Full Text] [Related]
16. Chinese Data of Efficacy of Low- and High-Dose Iodine-131 for the Ablation of Thyroid Remnant.
Ma C; Feng F; Wang S; Fu H; Wu S; Ye Z; Chen S; Wang H
Thyroid; 2017 Jun; 27(6):832-837. PubMed ID: 28401794
[TBL] [Abstract][Full Text] [Related]
17. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
Mäenpää H
Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
[TBL] [Abstract][Full Text] [Related]
18. Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.
Baskin HJ
Thyroid; 1994; 4(3):239-42. PubMed ID: 7833657
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma in children.
Antonelli A; Miccoli P; Fallahi P; Ferrari SM; Grosso M; Boni G; Berti P
Surgery; 2006 Dec; 140(6):1035-41; discussion 1041-2. PubMed ID: 17188154
[No Abstract] [Full Text] [Related]
20. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]